3E Bioventures

5AM Ventures

82VS

AbbVie

Accequa AB

Acelot

Aclipse Therapeutics

Actinogen Medical Ltd.

AcureX Therapeutics

adMare BioInnovations

age1 Fund I GP

Agile Capital Markets

AGTC Ventures LLC

Albion Ventures LLP

ALCEDIAG

Alpha Bronze

Alta Global Ventures

Alterity Therapeutics

Alto Neuroscience

Amyl Therapeutics

Andera Partners

Angelini Ventures

Aqua Partners LLC

Argobio Studio

Aruna Bio

ASDERA LLC

atai Life Sciences N.V.

ATEM Capital

Avestria Ventures

B'IMPRESS - impressive communication

BERNINA BioInvest Ltd.

BioAge Labs

BioCentury

Biogen

Bioqube Ventures

Bioscience Managers Pty Ltd

BIOSTART Consulting GmbH

BioSymetrics

Blackstone Life Sciences

Boehringer Ingelheim International GmbH

Bradley Woods & Co. Ltd.

Braintale

Brandon Capital

BTIG

Canaccord Genuity LLC

Cantor Fitzgerald

Capital Family Office

Cassel Salpeter & Co.

Catalytic Impact Foundation

CB Therapeutics

CBT Advisors

Cenna Biosciences

Centre for Aging + Brain Health Innovation (CABHI)

Cerecin Inc.

China Grand Enterprises

Class Bravo Ventures

Clexio Biosciences

Cognesy Therapeutics

Cognition Therapeutics

Compass Pathways

Complement Therapeutics Ltd

Consilium Strategic Communications

Cota Capital

Crosswave Management

CTI Life Sciences

Cukierman & Co. Investment House Ltd.

Cukierman & Co. Life Sciences

Cumulus Neuroscience

Daiichi Sankyo

David Fox Syndicate

DCVC Bio

Deerfield Management

DEFTA Partners

DigiTx Partners

Dorset Capital LLC

Droia Ventures

Easton Capital Investment Group

Edison Group

EF Hutton

Eight Roads Ventures

EIP Pharma

Eli Lilly and Company

Emyria

Enveric BioSciences

EQT Life Sciences

EryDel SpA

ESP Diagnostics Limited

Evecxia Therapeutics

F. Hoffmann-La Roche Ltd.

Ferghana Partners

Find Therapeutics Inc.

Forbion

Forty51 Ventures

Fraser Finance LLP

Freedom Capital Markets

FreeMind Group

Fundación de Neurociencias

Gate Neurosciences

Gen2 Neuroscience Ltd

Generation Fund Life Sciences Fund I

GeNeuro SA

Gershon MedTech

Gilgamesh Pharmaceuticals

Gimv

Global Emerging Markets (GEM)

Good Health Capital

GreenSky Capital

Gryphon Bio

H. Lundbeck A/S

H.C. Wainwright & Co.

Hanall Pharmaceutical International Inc.

Hatteras Venture Partners

HBM Partners AG

Health Innovation Capital

HEDA Ventures

Herantis Pharma Plc

Hestia Investments Ltd.

High-Tech Gründerfonds Management GmbH

Hunniwell Lake Ventures LLC

ICF Consult Switzerland

IDG Capital Partners

Ignite Capital Partners

Illumina Accelerator

Illumina Ventures

Immuneering Corporation

IMMvention Therapeutix

Impact India Investment Partners

Indaco Venture Partners SGR S.p.A.

Independent

InGel Therapeutics

Intermediate Capital Group PLC

Inveready Asset Management

Invest Hong Kong

IPF Management S.A.

Ipsen

IRLAB Therapeutics AB

Janssen Research & Development

JCR Pharmaceuticals

Jeito Capital

JLS Fund LP

Johnson & Johnson Innovation – JJDC

Johnson & Johnson Innovation LLC

Johnston Associates

JPMorgan Chase & Co.

JT Pharma

Kaleida Capital

Katan Associates

KeifeRx

Keystone Bio

Korys Investments NV

Kures

Ladenburg Thalmann & Co. Inc.

Landmark Angels

Leaps by Bayer

LikeMinds

Lilly Asia Ventures

LMU Munich

LongeVC

Lucia Capital

Lumanity

Lumira Ventures

Lundbeckfonden BioCapital Ventures

M Ventures

Mass General Brigham Ventures

MedTech Strategist

Merck & Co.

Mid Atlantic Bio Angels

Monument Therapeutics Limited

MUFG Union Bank

Mytos Bio

National Institute of Neurological Disorders and Stroke (NINDS)

National Institute on Aging

NETRI

Neumora Therapeutics

Neuraly Inc.

Neuro-Innovators

Neurocentria

Neuromod Devices

NeuroPn Therapeutics

Neuroscience Trials Australia

Neurotech Reports

Neurovascular Research & Design

Neurvati Neurosciences

New Harbor Venture Partners

New Science Global Healthcare Fund

NI Research Inc.

Noble Life Science Partners

Noema Pharma AG

Novartis AG

Novo Holdings

NRx Pharmaceuticals

Oceaniq Capital

Oculis SA

OcuTerra Therapeutics

OcuTerra Therapeutics Inc.

Ontario Brain Institute

Ontario Teachers' Pension Plan Board

Oppenheimer & Co. Inc.

Optimum Strategic Communications

OrbiMed Advisors LLC

Oryzon Genomics

Osage University Partners

Palo Alto Investors

Panakès Partners SGR SpA

Pangea Botania Ltd

Pappas Capital

Pepper Bio

Perceptive Advisors

Pharmaphorum Media Limited

PharmaVentures Ltd.

PJT Partners

Plich Advisory & Investments B.V.

Praesidia Biotherapeutics

Prevail Partners LLC

Primary Peptides Inc.

Pritzker Neuropsychiatric Disorders Research Consortium

Profound Ventures

Prothena Corporation

Protobios

Psilera Inc.

Pureos Bioventures

Qiming Venture Partners

Qynapse Inc.

Ray Therapeutics

Raya Therapeutic

re.Mind Capital Ltd.

Recode Health Ventures

Remiges Ventures

ReST THERAPEUTICS

Robeauté

Roth Capital Partners

Rune Labs

RYSE Asset Management

Sand Hill Angels

Sandman Financial

Seventure Partners

Shadow Lake Group Inc.

Silicon Valley Bank

Silicon Valley Ventures

Simcere Pharmaceutical Group

Sixty Degree Capital

Sofinnova Investments

Sofinnova Partners

Sony Innovation Fund

Sound Bioventures Management AB

SR One

STALICLA SA

Stanford University

SternAegis Ventures

Stifel Europe

SV Health Investors LLP

Takeda Development Center Americas

Talu Ventures

Tesarakt Inc.

The Benchmark Company

The Centre for Addiction & Mental Health (CAMH)

The Michael J. Fox Foundation for Parkinson's Research

Theranexus S.A.

Tiberend Strategic Advisors

TikoMed AB

Torreya

Toscana Ventures

Treo Ventures

TruVenturo GmbH

Twin Oaks Capital

Unlearn.AI

V-Bio Ventures

Valor Management S.A.

Ventac Partners A/S

Venture Valuation

Vine Ventures Real LLC

Vista Capital Advisors

Viva BioInnovator

WBB Securities

Wellington Partners

Wells Fargo Bank N.A.

WISE S.r.l.

WPSS.bio

WRF Capital

XOventure GmbH